Aether Industries

831.00
-3.85
(-0.46%)
Market Cap
11,018.25 Cr
EPS
6.31
PE Ratio
95.77
Dividend Yield
0.00 %
Industry
Chemicals
52 Week High
1,071.00
52 Week Low
738.50
PB Ratio
5.10
Debt to Equity
0.06
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from5 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy+100.00 %
+100.00 %
Hold0.0 %
0.0 %
Sell0.0 %
0.0 %
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
2,849.30
#1 1,44,928.95
72.68
12,522.60
#1 5.69
#1 1,747
9.04
59.88
2,939.15
87,123.70
76.00
13,221.50
-11.53
1,336
6.99
54.72
4,022.85
44,191.01
96.50
4,387.70
-25.09
435
57.50
64.96
1,983.60
27,054.92
39.29
7,757.90
-3.26
811
-51.46
44.07
424.35
20,949.36
41.15
4,227.40
0.66
411
29.69
46.24
4,210.85
20,874.67
79.21
2,120.90
0.37
271
7.18
59.68
4,423.70
19,148.27
#1 32.04
#1 13,843.30
-
563
-26.05
44.15
6,136.60
18,067.23
40.95
4,783.90
-13.69
324
#1 62.41
62.65
1,580.95
16,389.02
42.39
1,938.80
-8.77
323
21.85
46.38
390.75
14,165.47
39.26
6,380.70
-3.61
417
-62.90
43.54
Growth Rate
Revenue Growth
-4.52 %
Net Income Growth
-36.73 %
Cash Flow Change
-150.91 %
ROE
-61.83 %
ROCE
-59.96 %
EBITDA Margin (Avg.)
-11.45 %

Quarterly Financial Results

Quarterly Financials
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
151
145
154
148
166
147
171
184
163
178
167
129
192
210
233
Expenses
104
101
112
105
118
103
120
124
116
118
130
115
140
149
158
EBITDA
48
44
42
42
49
43
51
60
47
60
36
14
52
61
76
Operating Profit %
31 %
29 %
26 %
29 %
27 %
26 %
28 %
32 %
28 %
28 %
16 %
2 %
22 %
25 %
28 %
Depreciation
4
3
4
4
5
5
6
7
9
10
10
10
10
11
11
Interest
3
3
4
3
3
1
0
1
1
2
2
4
3
2
3
Profit Before Tax
40
37
34
35
41
37
44
52
37
49
24
0
39
49
61
Tax
8
12
8
9
11
10
9
15
7
12
6
2
9
14
18
Net Profit
32
25
25
26
31
27
35
38
30
37
17
-1
30
35
43
EPS in ₹
32.01
24.93
2.28
2.31
2.46
2.19
2.81
3.02
2.25
2.77
1.32
-0.11
2.26
2.63
3.27

Balance Sheet

Balance Sheet
2022
2023
2024
Total Assets
770
1,380
2,401
Fixed Assets
257
646
854
Current Assets
410
675
1,303
Capital Work in Progress
58
37
232
Investments
17
1
0
Other Assets
438
695
1,315
Total Liabilities
770
1,380
2,401
Current Liabilities
242
94
289
Non Current Liabilities
141
41
48
Total Equity
387
1,245
2,063
Reserve & Surplus
274
1,120
1,931
Share Capital
113
125
133

Cash Flow

Cash Flow
2022
2023
2024
Net Cash Flow
12
84
453
Investing Activities
-151
-348
-424
Operating Activities
-5
-7
-17
Financing Activities
169
439
894

Share Holding

% Holding
Dec 2021
May 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
98.71 %
87.09 %
87.09 %
87.09 %
87.07 %
87.07 %
81.81 %
81.81 %
81.79 %
81.79 %
81.79 %
81.79 %
81.77 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
1.98 %
2.22 %
2.90 %
3.17 %
3.33 %
DIIs
0.00 %
4.56 %
7.58 %
7.64 %
8.35 %
8.39 %
12.95 %
12.23 %
11.80 %
11.82 %
11.56 %
11.63 %
11.49 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
3.87 %
1.71 %
1.93 %
2.01 %
1.94 %
1.85 %
2.10 %
3.60 %
3.42 %
3.10 %
2.82 %
2.77 %
Others
1.29 %
4.47 %
3.62 %
3.33 %
2.57 %
2.60 %
3.39 %
3.86 %
0.83 %
0.74 %
0.65 %
0.59 %
0.63 %
No of Share Holders
27
80,855
51,639
57,529
56,840
53,456
53,389
60,466
84,000
78,655
71,683
67,251
66,677

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Integrated Filing (Financial)Mar 03, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 10, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 04, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 31, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 31, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJan 30, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 27, 2025
Intimation For Procurement Of Industrial PremisesJan 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 23, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 22, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 21, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJan 20, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 20, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 18, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJan 18, 2025
Statement Of Deviation Or Variation In The Use Of Proceeds Of Qualified Institutions Placement (QIP)Jan 18, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportJan 18, 2025
Audio Recording Of The Earning Call Held On January 17 2025Jan 18, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJan 17, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On January 17 2025Jan 17, 2025
Unaudited Financial Results For The Q3 / 9M Ended On 31.12.2024Jan 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 15, 2025
Execution Of Amendment To Strategic Supply Agreement With Baker HughesJan 15, 2025
Intimation Of Credit RatingJan 13, 2025
Update On The Board Meeting To Be Held On Friday January 17 2025Jan 13, 2025
Revocation Order From GPCB For Resumption Of Operations At Manufacturing Facility IIJan 09, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 08, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJan 06, 2025
Final Execution And Commissioning Of 15 MW Solar Power Project (Auto-Tracker Modules) FacilityDec 30, 2024
Grant Of Stock Options Under AIL ESOS 2021Dec 17, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeDec 11, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeDec 11, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeDec 10, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeDec 09, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 05, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeDec 02, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 02, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 26, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 21, 2024
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSNov 20, 2024

Technical Indicators

RSI(14)
Neutral
43.79
ATR(14)
Less Volatile
33.40
STOCH(9,6)
Oversold
14.85
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
-7.03
ADX(14)
Weak Trend
23.62
UO(9)
Bearish
38.48
ROC(12)
Downtrend And Accelerating
-10.93
WillR(14)
Oversold
-93.07